Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.440
+0.007 (0.49%)
At close: Sep 18, 2026, 4:00 PM EDT
1.440
0.00 (0.01%)
After-hours: Sep 18, 2026, 6:39 PM EDT
Pulmatrix Earnings Call Transcripts
Fiscal Year 2024
-
Pulmatrix and Cullgen will merge, with Cullgen stockholders owning 96.4% of the combined entity, which will operate under the Cullgen name and focus on targeted protein degraders and DACs. The merger, expected to close by March 2025, brings $65M in cash and a robust clinical pipeline.